<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-35523" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Epiretinal Membrane</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kanukollu</surname>
            <given-names>Venkata M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Agarwal</surname>
            <given-names>Prateek</given-names>
          </name>
          <aff>Cleveland Clinic Abu Dhabi</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venkata Kanukollu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prateek Agarwal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-35523.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Epiretinal membrane is a commonly occurring condition affecting the posterior pole of the retina over the macula. It appears as a greyish semi-translucent avascular membrane over the internal limiting membrane (ILM) on the surface of the retina. Etiology is unknown and can be seen as an idiopathic (IERM) condition or secondary to trauma, post intraocular surgery, chronic ocular diseases, etc. It progressively affects the central vision and causes metamorphopsia. This activity reviews the evaluation and treatment of the epiretinal membrane and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of the epiretinal membrane.</p></list-item><list-item><p>Describe the appropriate evaluation of the epiretinal membrane.</p></list-item><list-item><p>List the management options available for the epiretinal membrane.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and improve outcomes in the management of the epiretinal membrane.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35523&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35523">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-35523.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>In 1865, Iwanoff described an epiretinal membrane (ERM) as the proliferation of cellular tissue on the surface of the retina along the inner limiting membrane. Its&#x000a0;a commonly occurring condition, affecting the posterior pole of the retina over the macula. It appears as a greyish semi-translucent avascular membrane over the internal limiting membrane (ILM) on the surface of the retina. The other synonyms for ERM are macular pucker, preretinal macular fibrosis, surface wrinkling retinopathy, epimacular proliferations, epiretinal fibrosis or gliosis, and cellophane maculopathy.</p>
        <p>Etiology is unknown and can be seen as an idiopathic (IERM) condition or secondary to trauma, post intraocular surgery, chronic ocular diseases, etc. It progressively affects the central vision and causes metamorphopsia. Optical coherence tomography (OCT) is the diagnostic procedure of choice for diagnosing and assessing the extent of the epiretinal membrane and its impact on the retinal morphology. Treatment, when indicated, is pars-plana vitrectomy (PPV) with ERM and ILM peeling.</p>
      </sec>
      <sec id="article-35523.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Etiology is unknown, and the most common cause of the epiretinal membrane (ERM) is idiopathic (IERM). Secondary epiretinal membranes are seen in trauma, intraocular surgery, post-macular lasers, diabetic retinopathy, retinal vein occlusion, chronic macular edema, chronic intraocular inflammation, retinal detachment, and intraocular tumors. Increasing age, ERM in the other eye, and posterior vitreous detachment (PVD) are other risk factors. Several other names for ERM include cellophane maculopathy, macular pucker, preretinal fibrosis, and preretinal membrane. A systemic review involving 49,000 subjects found that greater age and female gender are significant risk factors for ERM.<xref ref-type="bibr" rid="article-35523.r1">[1]</xref></p>
      </sec>
      <sec id="article-35523.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The most common type of epiretinal membranes is idiopathic and is common in patients over the age of 50. Approximately 20% of patients over the age of 75 have an epiretinal membrane with both sexes equally affected. Some reports show a slightly higher incidence in females.</p>
        <p>In a multi-ethnic study of the United States population done in 2011 involving 5960 participants aged 45 to 84 years, it was shown that Chinese(39%) show significantly higher prevalence compared to Hispanics (29.3%), Whites (27.5%) and Blacks (26.2%).<xref ref-type="bibr" rid="article-35523.r2">[2]</xref>&#x000a0;Increasing age, diabetes, and hypercholesteremia were found to be risk factors for the epiretinal membrane.&#x000a0;</p>
        <p>In a multicentric meta-analysis of population-based studies involving 40,000 participants, it was shown that 9% had some form of ERM. Epiretinal membranes are classified into two groups: one with retinal folds called preretinal macular fibrosis (PMF) and second without retinal folds called cellophane macula reflex (CMR). Of the ERM patients, 6.5% had CMR, and 2.6% had an advanced form of PMF. Older and female participants showed a higher risk.<xref ref-type="bibr" rid="article-35523.r1">[1]</xref>&#x000a0;</p>
        <p>The Blue Mountains study&#x000a0;was done over five years to study the incidence and progression of epiretinal membranes in the older Australian population.<xref ref-type="bibr" rid="article-35523.r3">[3]</xref> Three thousand six hundred fifty-four persons, 49 years or older, living in the Blue Mountains area, west of Sydney, Australia, participated in the study from 1992 to 1994. The mean age was&#x000a0; 65 years. The incidence of ERM&#x02019;s in the first eye was 5.3%, and the progression of early ERM to an advanced stage of ERM of 9.3%. Five-year cumulative incidence rates of PMF and CMR were 1.5% and 3.8 %, respectively. Of these, 13.9% developed ERM in their second eye after five years.</p>
      </sec>
      <sec id="article-35523.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>A fibrocellular proliferation over the internal limiting membrane (ILM) characterizes the epiretinal membrane (ERM). The initiating event in an idiopathic ERM is the posterior vitreous detachment (PVD). Aging vitreous liquefies and detaches from its posterior attachments leading to posterior vitreous detachment. PVD causes dehiscence in the internal limiting membrane, which allows the microglial cells to migrate to the preretinal surface where they interact with the hyalocytes and laminocytes of the vitreous cellular membrane. These cells later transdifferentiate into fibroblast-like cells to form a cellophane thin epiretinal membrane.<xref ref-type="bibr" rid="article-35523.r4">[4]</xref>&#x000a0;PVD causes 95% of cases of idiopathic ERM.<xref ref-type="bibr" rid="article-35523.r5">[5]</xref>&#x000a0;Retinal folds from ERM contracts to create a macular pucker. Retinal glial cells, hyalocytes, fibroblasts, and myofibroblasts are predominantly seen in idiopathic ERM. Retinal pigment epithelial cells, macrophages, T, and B cells are seen in secondary ERM as inflammation is the triggering event. A prerequisite for the formation of ERM is dehiscence in the ILM most commonly caused by posterior vitreous detachment. The following are the theories hypothesized for the ERM formation:</p>
        <list list-type="bullet">
          <list-item>
            <p>Microglial cells migrate to the retinal surface over micro leaks produced by PVD. These cells later differentiate to form the fibroblasts.<xref ref-type="bibr" rid="article-35523.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Following PVD, segments of cellular vitreous remain on the surface. These segments contain hyalocytes that transdifferentiate into myofibroblasts from ERM.<xref ref-type="bibr" rid="article-35523.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>PVD induced ILM avulsion in the posterior paravascular retina upregulates the cytokines to form the ERM.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35523.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most often, patients with epiretinal membrane (ERM) are asymptomatic clinically and are frequently diagnosed during a routine clinical examination. In some patients, ERM progresses to cause metamorphopsia, micropsia or macropsia, photopsia, decreased visual acuity, diplopia, and loss of central vision. Metamorphopsia especially interferes with the quality of life affecting reading, writing, and most of the regular day-to-day activities of living. All asymptomatic patients should be trained to do self-monitoring periodically with Amsler grid charting. History taking should include previous ocular trauma or episodes of floaters or flashes of light, diabetes, hypertension, and hypercholesteremia. ERM causes retinal striae, which progresses in some patients to retinal folds, progressive contracture, and macular pseudohole. Rarely spontaneous separation of the membrane occurs, causing premacular floaters.</p>
      </sec>
      <sec id="article-35523.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Idiopathic epiretinal membrane (IERM) is commonly seen in the elderly beyond 60 years with no sex predilection. Visual acuity, Amsler grid charting, and dilated fundus examination with scleral depression is mandatory in all patients with visual distortion. Watzke Allen test is an ophthalmoscopic test done to differentiate the full-thickness macular hole from a pseudohole. On the slit-lamp fundus examination, the epiretinal membrane (ERM) appears as an abnormal reflectivity of the macular area with loss of normal convex contour and fine wrinkling of the surface. ERM is classified as an early milder form called cellophane macular reflex and a severe late form called preretinal macular fibrosis.<xref ref-type="bibr" rid="article-35523.r4">[4]</xref>&#x000a0;</p>
        <p>Cellophane macular reflex is seen as a thin transparent membrane overlying the macula with no distortion or impairment of vision. Fundoscopy shows a glistening watery silky light reflex over the macula. Preretinal macular fibrosis occurs in some cases where a cellophane membrane thickens, contracts causing retinal folds and traction lines resulting in impairment of vision and metamorphopsia. Fundoscopy of preretinal macular fibrosis reveals a semi-translucent membrane obscuring the underlying retinal details with retinal fold, traction lines, and vascular tortuosity. Severe cases might show retinal hemorrhages, exudates, macular edema, macula hole, and pseudohole. A defect in the ERM appears as a pseudohole.</p>
        <p>Optical coherence tomography (OCT) is a highly sensitive routinely done investigation for retinal disorders and is the investigation of choice to diagnose epiretinal membrane and vitreomacular traction (VMT). On OCT, an ERM appears as a hyperreflective layer often irregular over the inner surface of the retina. It appears corrugated with peg-like attachments to the retina. Elevation of the foveal depression is seen due to traction from ERM. In severe cases, the inner retina shows folds with thickening of macula along with cystoid spaces. Both ERM and VMT often occur together. Andrea Govetto et al. have studied 194 eyes of 172 patients with ERM with clinical charts and spectral-domain OCT imaging. They found 63 out of 194 eyes showed the presence of continuous ectopic inner foveal layers and is associated with lower visual acuity.<xref ref-type="bibr" rid="article-35523.r8">[8]</xref>&#x000a0;They proposed the OCT-based grading system of ERMs as below:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 1: ERMs were mild and thin. Foveal depression is present.</p>
          </list-item>
          <list-item>
            <p>Stage 2: ERMs with a widening of the outer nuclear layer and loss of the foveal depression.</p>
          </list-item>
          <list-item>
            <p>Stage 3: ERMs with continuous ectopic inner foveal layers crossing the entire foveal area.</p>
          </list-item>
          <list-item>
            <p>Stage 4: ERMs were thick with continuous ectopic inner foveal layers and disrupted retinal layers.</p>
          </list-item>
        </list>
        <p>In stages 1, 2, and 3, all retinal layers were clearly defined on OCT. Visual acuity progressively declined from stage 1 through stage 4. Hwang classified idiopathic ERM based on spectral-domain OCT.<xref ref-type="bibr" rid="article-35523.r9">[9]</xref></p>
        <p>Group 1: Fovea-involving ERM</p>
        <list list-type="bullet">
          <list-item>
            <p>1a: Outer retinal thickening and minimal inner retinal change</p>
          </list-item>
          <list-item>
            <p>1b: Outer retinal inward projection and inner retinal thickening</p>
          </list-item>
          <list-item>
            <p>1c: Prominent thickening of the inner retinal layer</p>
          </list-item>
        </list>
        <p>Group 2: Fovea-sparing ERM</p>
        <list list-type="bullet">
          <list-item>
            <p>2a: Formation of a macular pseudohole</p>
          </list-item>
          <list-item>
            <p>2b: Schisis-like intraretinal splitting</p>
          </list-item>
        </list>
        <p>Dr. Altaweel et al. recently proposed a detailed staging based on OCT observations.<xref ref-type="bibr" rid="article-35523.r10">[10]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Stage IA: Foveal splitting with a pseudocyst&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Stage IB: Pseudocyst enlargement and extension to the outer retina with roof intact.</p>
          </list-item>
          <list-item>
            <p>Stage IIA:&#x000a0;Full-thickness macular hole (diameter &#x0003c;400 microns) with posterior hyaloid face remaining attached to the roof of the pseudocyst.</p>
          </list-item>
          <list-item>
            <p>Stage IIB: Full-thickness macular hole (diameter &#x0003c;400 microns) with an operculum.</p>
          </list-item>
          <list-item>
            <p>Stage III: Full-thickness macular hole (diameter &#x0003e;400 microns) with surrounding thickened retina, including intraretinal cystoid spaces. The perifoveal and prefoveal hyaloid is separated from the macular retina.</p>
          </list-item>
          <list-item>
            <p>Stage IV: A stage III hole with a complete posterior vitreous detachment. OCT often cannot visualize the posterior hyaloid because it is too anterior.</p>
          </list-item>
        </list>
        <p>A fundus fluorescein angiography or an optical coherence angiography (OCT-A) will help in detecting the retinal pathologies causing secondary ERM such as diabetic retinopathy, choroidal neovascular membrane, retinal telangiectasias, retinal vein occlusions, etc.</p>
      </sec>
      <sec id="article-35523.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Most patients with epiretinal membrane (ERM) do not require treatment if it doesn&#x02019;t affect vision or cause significant metamorphopsia. Blue Mountains study <xref ref-type="bibr" rid="article-35523.r3">[3]</xref>&#x000a0;involving 3654 subjects showed that only 20% of epiretinal membranes progressed over five years, 26% regressed, and 39% remained the same. Only 20% of eyes with cellophane maculopathy progressed over a while. The primary treatment for ERM apart from observation is surgical. Surgery for ERM has a reasonable success rate, and most patients show improvement in visual acuity and a decrease in metamorphopsia. Hence the aim of treatment for ERM should be to preserve or improve vision, minimize symptoms like metamorphopsia, diplopia, etc. and enhance the quality of life. Factors that affect the visual outcome include the duration of the condition, the degree of vitreomacular traction, and the cause for ERM. Idiopathic ERM has a better prognosis than ERM secondary to ocular pathology.</p>
        <p>Non-surgical management includes the use of vitreopharmacolysis with ocriplasmin. Ocriplasmin is a recombinant proteolytic enzyme approved by the FDA for intravitreal injection for the treatment of symptomatic VMT. Ocriplasmin can relieve the VMT associated with ERM, which might provide relief from the associated metamorphopsia. It does not affect ERM. Its use in patients with both ERM and VMT is controversial. In patients unfit for lengthy retinal surgical procedures, intravitreal ocriplasmin can treat visual disturbances induced by VTM.</p>
        <p>Surgical management involves pars-plana vitrectomy (PPV) with ERM and ILM peeling. PPV with membrane peeling has been used successfully for many decades, with an excellent visual outcome and a reduced recurrence rate. ILM is thought to provide a platform for the proliferation of fibroblasts, glial cells, and astrocytes for the retina to form ERM.<xref ref-type="bibr" rid="article-35523.r11">[11]</xref> ILM peeling along with membrane peeling has become a standard procedure following the advent of staining dyes like trypan blue, indocyanine green (ICG), and brilliant blue G (BBG).<xref ref-type="bibr" rid="article-35523.r12">[12]</xref> Triamcinolone is used to stain the vitreous and the membrane. Triamcinolone staining helps to induce posterior vitreous detachment and to ensure an excellent subtotal vitrectomy. Accelerated nuclear sclerosis or a worsening of cataract is the most common complication of vitrectomy. If a cataract is present, the procedure should be combined with a cataract removal to ensure better visualization of the surgical procedure and also to prevent a subsequent second surgery.</p>
        <p>Dye assisted ILM peeling has resulted in better visual outcomes, fewer recurrence rates, and reduced retinal striae.<xref ref-type="bibr" rid="article-35523.r13">[13]</xref> Although ILM peeling is beneficial, it is also believed that it might cause damage to muller cells as ILM is the basal lamina which is connected to the endfeet of muller cells.<xref ref-type="bibr" rid="article-35523.r14">[14]</xref><xref ref-type="bibr" rid="article-35523.r15">[15]</xref><xref ref-type="bibr" rid="article-35523.r16">[16]</xref> Due to this uncertainty of the effectiveness versus the damage caused by ILM peeling in idiopathic ERM, many studies have been conducted comparing single peeling (only ERM) and double peeling (ERM and ILM peeling). Vitrectomy with ILM peeling results in visual improvement in long-term follow-ups and lower ERM recurrence rates. While vitrectomy with only ERM peeling is more efficacious in the reduction of a central retinal thickness (CRT) than with vitrectomy with ILM peeling.<xref ref-type="bibr" rid="article-35523.r17">[17]</xref></p>
      </sec>
      <sec id="article-35523.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical appearance of the epiretinal membrane (ERM) is clearly remarkable. However, some conditions mimic an epiretinal membrane during their early stages:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fine vessel tortuosity: Combined hamartoma of retina and RPE</p>
          </list-item>
          <list-item>
            <p>Membrane over the retina: Proliferative vitreoretinopathy and tractional retinal detachment.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35523.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Epiretinal membrane (ERM) is asymptomatic in its early stage with a good prognosis. Blue Mountains study reveals 39% of the membranes to be non-progressive. Progressive ERM reduces vision and causes annoying metamorphopsia. For worsening ERM, pars plana vitrectomy with membrane and ILM peeling has an excellent prognosis both by improving visual acuity and reducing metamorphopsia. The recurrence of ERM ranges from 1%<xref ref-type="bibr" rid="article-35523.r18">[18]</xref>&#x000a0;to 21%.<xref ref-type="bibr" rid="article-35523.r13">[13]</xref></p>
        <p>The recurrence and incomplete recovery of final visual acuity are due to incomplete removal of the membrane. Additional peeling of ILM removes the platform for cellular proliferation. One study has suggested that photoreceptor disruption detected by&#x000a0;OCT&#x000a0;and P1 implicit time delay on multifocal electroretinogram as significant predictors for poor visual recovery after ERM surgery.<xref ref-type="bibr" rid="article-35523.r19">[19]</xref> To date, the most determining risk factor, which predicts the post-operative visual recovery, is the duration of the ERM.</p>
      </sec>
      <sec id="article-35523.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Epiretinal membrane (ERM) can cause various ocular complications, and these include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Accelerated nuclear sclerosis or cataract formation</p>
          </list-item>
          <list-item>
            <p>Retinal breaks or detachment</p>
          </list-item>
          <list-item>
            <p>Macular toxicity (trauma/light)</p>
          </list-item>
          <list-item>
            <p>Endophthalmitis</p>
          </list-item>
          <list-item>
            <p>Macular hole</p>
          </list-item>
          <list-item>
            <p>Vitreous hemorrhage</p>
          </list-item>
          <list-item>
            <p>Retinal petechiae/hemorrhage</p>
          </list-item>
          <list-item>
            <p>The dissociated optic nerve fiber layer</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35523.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be informed that most epiretinal membranes which do not affect the vision or cause metamorphopsia are best left alone. Periodic self-assessment with Amsler grid charts would help one to assess the beginning or progression of metamorphopsia. Besides, self-monitoring monocular vision also helps to detect early central vision changes. Patients should also be made aware that surgical procedures for epiretinal membrane (ERM) are very successful in addressing visual acuity symptoms and improve quality of life. Patient education and appropriate counseling will help patients to have realistic expectations.</p>
      </sec>
      <sec id="article-35523.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Diagnosis and management of the epiretinal membrane (ERM) require appropriate diagnostic and surgical skills in addition to the availability of special equipment. Even though the diagnostic procedures are done by trained personnel, interpretation and diagnosis are made by a trained ophthalmologist. Hence appropriate referral to an ophthalmologist is mandatory for patients who present to primary eye care with decreased visual acuity and metamorphopsia unresolved by refractory correction. Surgical management needs intervention from a retinal surgeon, and hence a liaison between a general ophthalmologist or optometrist is mandatory in the care of patients with epiretinal membranes.</p>
      </sec>
      <sec id="article-35523.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35523&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35523">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/epiretinal-membrane/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=35523">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/35523/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=35523">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-35523.s15">
        <fig id="article-35523.image.f1" position="float" orientation="portrait">
          <caption>
            <p>SD-OCT (macular scan) showing epiretinal membrane (ERM) with full-thickness macular hole (FTMH) Contributed by Soumyadeep Majumdar, MS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="SD-OCT__xmacular__scanx__showing__Epi-retinal__membrane__xERMx__with__full-thickness__macular__hole__xFTMHx" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-35523.s16">
        <title>References</title>
        <ref id="article-35523.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and risk factors of epiretinal membranes: a systematic review and meta-analysis of population-based studies.</article-title>
            <source>BMJ Open</source>
            <year>2017</year>
            <month>Sep</month>
            <day>25</day>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>e014644</fpage>
            <pub-id pub-id-type="pmid">28951399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ng</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Kawasaki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meuer</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Cotch</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population.</article-title>
            <source>Ophthalmology</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>118</volume>
            <issue>4</issue>
            <fpage>694</fpage>
            <page-range>694-9</page-range>
            <pub-id pub-id-type="pmid">21035863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraser-Bell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guzowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rochtchina</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study.</article-title>
            <source>Ophthalmology</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-40</page-range>
            <pub-id pub-id-type="pmid">12511343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevenson</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Prospero Ponce</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Gelman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Christoforidis</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Epiretinal membrane: optical coherence tomography-based diagnosis and classification.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2016</year>
            <volume>10</volume>
            <fpage>527</fpage>
            <page-range>527-34</page-range>
            <pub-id pub-id-type="pmid">27099458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiznia</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Posterior vitreous detachment and idiopathic preretinal macular gliosis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1986</year>
            <month>Aug</month>
            <day>15</day>
            <volume>102</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-8</page-range>
            <pub-id pub-id-type="pmid">3740180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foos</surname>
                <given-names>RY</given-names>
              </name>
            </person-group>
            <article-title>Vitreoretinal juncture; epiretinal membranes and vitreous.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1977</year>
            <month>May</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>416</fpage>
            <page-range>416-22</page-range>
            <pub-id pub-id-type="pmid">852943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamashita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Uemura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative characteristics of the posterior vitreous cortex in patients with epiretinal membrane.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>246</volume>
            <issue>3</issue>
            <fpage>333</fpage>
            <page-range>333-7</page-range>
            <pub-id pub-id-type="pmid">18193261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Govetto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lalane</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sarraf</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Figueroa</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Hubschman</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Insights Into Epiretinal Membranes: Presence of Ectopic Inner Foveal Layers and a New Optical Coherence Tomography Staging Scheme.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>175</volume>
            <fpage>99</fpage>
            <page-range>99-113</page-range>
            <pub-id pub-id-type="pmid">27993592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hwang</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Joe</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>YH</given-names>
              </name>
            </person-group>
            <article-title>Assessment of macular function for idiopathic epiretinal membranes classified by spectral-domain optical coherence tomography.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2012</year>
            <month>Jun</month>
            <day>14</day>
            <volume>53</volume>
            <issue>7</issue>
            <fpage>3562</fpage>
            <page-range>3562-9</page-range>
            <pub-id pub-id-type="pmid">22538422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Altaweel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ip</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>58</fpage>
            <page-range>58-66</page-range>
            <pub-id pub-id-type="pmid">14566624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Bustros</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Michels</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Vitrectomy for idiopathic epiretinal membranes causing macular pucker.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1988</year>
            <month>Sep</month>
            <volume>72</volume>
            <issue>9</issue>
            <fpage>692</fpage>
            <page-range>692-5</page-range>
            <pub-id pub-id-type="pmid">3179258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farah</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Dyes in ocular surgery: principles for use in chromovitrectomy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>148</volume>
            <issue>3</issue>
            <fpage>332</fpage>
            <page-range>332-40</page-range>
            <pub-id pub-id-type="pmid">19477708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Dugel</surname>
                <given-names>PU</given-names>
              </name>
              <name>
                <surname>Garda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sipperley</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Thach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sneed</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Blaisdell</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Macular pucker removal with and without internal limiting membrane peeling: pilot study.</article-title>
            <source>Ophthalmology</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-4</page-range>
            <pub-id pub-id-type="pmid">12511347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uemoto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsukahara</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>86</volume>
            <issue>11</issue>
            <fpage>1240</fpage>
            <page-range>1240-2</page-range>
            <pub-id pub-id-type="pmid">12386079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terasaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miyake</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nomura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Piao</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Hori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Niwa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>229</fpage>
            <page-range>229-34</page-range>
            <pub-id pub-id-type="pmid">11133873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uemura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kanda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kita</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>136</volume>
            <issue>2</issue>
            <fpage>252</fpage>
            <page-range>252-7</page-range>
            <pub-id pub-id-type="pmid">12888046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Tung</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Vitrectomy with or without internal limiting membrane peeling for idiopathic epiretinal membrane: A meta-analysis.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>e0179105</fpage>
            <pub-id pub-id-type="pmid">28622372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>OP</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2008</year>
            <month>May</month>
            <volume>145</volume>
            <issue>5</issue>
            <fpage>923</fpage>
            <page-range>923-8</page-range>
            <pub-id pub-id-type="pmid">18329000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35523.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Structural and functional predictors of visual outcome of epiretinal membrane surgery.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>153</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-10.e1</page-range>
            <pub-id pub-id-type="pmid">21937015</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
